SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

NVTS is trending due to its partnership with NVDA to co-develop GaN & SiC power semiconductors for NVIDIA’s 800V AI factory systems, sparking significant after-hours volume. The community is discussing potential price targets and whether the stock will experience a short squeeze, recognizing NVTS's role in powering the AI boom. With a focus on long-term AI infrastructure, traders are closely watching valuation and revenue potential.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors discuss Shah Capital's push for the company's sale to a larger pharmaceutical entity to unlock shareholder value. The community is debating the potential buyout price, partnership opportunities, and the company's future prospects under new ownership. Some are frustrated with current management, while others remain optimistic about Novavax's fundamentals and technology.

Nova Minerals Ltd. engages in the exploration and development of mineral properties. Its projects include Estelle Gold, RPM, Korbel, Train, Stoney and Studies projects. The company was founded in January 1987 and is headquartered in Melbourne, Australia.

Nova Minerals Limited - ADR

Nova Minerals is trending due to positive updates on their Alaskan gold and antimony project, including high-grade gold assay results and news of extinguished debt, sparking investor interest. The community is discussing the company's potential to benefit from increased antimony prices and its undervalued status compared to peers. There is also speculation about the company receiving government grants to develop a domestic antimony supply chain.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

$RAGE is surging as the community rallies around the 'OG meme' narrative, evoking a sense of nostalgia and shared internet history. Fuelled by a wave of bullish sentiment, community members are expressing strong conviction. The community believes $RAGE represents a cultural movement, with many anticipating a 'moonshot'.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst is trending as investors discuss the company's acquisition of Astria Therapeutics for $700M, a move aimed at bolstering their HAE portfolio with a late-stage, long-acting plasma kallikrein inhibitor; navenibart. Community chatter revolves around the deal's financial implications, potential dilution, and the strategic shift from in-house development to acquisitions, with some expressing concerns over increased debt and the timeline for potential returns while others are optimistic about the company's strengthened position in the HAE market.

Greenwave Technology Solutions, Inc. is an emerging growth company, which engages in recycling ferrous metal. It also recycles nonferrous metals including aluminum, copper, stainless steel, nickel, brass, titanium, lead, alloys, and mixed metal products. The company was founded on April 26, 2013 and is headquartered in Chesapeake, VA.

Greenwave Technology Solutions Inc

GWAV is trending due to a planned reverse stock split, which is sparking discussions about potential short squeezes and future price movements. While some traders are optimistic about quick gains, others express concern over the company's history of reverse splits and potential dilution. The community is actively debating the stock's short-term potential versus long-term risks.

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as the community debates its recent price volatility and potential support levels, with some anticipating a drop below $100K while others foresee a sharp reversal and new highs. Discussions also involve the impact of potential trade wars and broader macroeconomic factors on BTC's price action. Some traders point to technical indicators and whale activity as drivers of current market movements.

American Resources Corp. engages in the extraction, processing, transportation, and distribution of metallurgical coal to the steel industry. It focuses on the operation of coal mining complexes located primarily within Pike, Knott, and Letcher Counties, Kentucky, and Wyoming County, West Virginia. The company was founded in 2006 and in headquartered in Fishers, IN.

American Resources Corporation - Ordinary Shares - Class A

American Resources Corporation ($AREC) is trending due to ongoing discussions around rare earth elements and critical minerals, particularly following news of a $33M financing deal. The community is debating the implications of potential dilution versus the benefits of increased capital for expansion, especially regarding ReElement Technologies and government interest. Some investors express concerns about past performance and management, while others are optimistic about the company's role in the domestic rare earth supply chain and potential for a ReElement IPO.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

CADL is trending due to positive community sentiment surrounding non-dilutive funding and the potential for Phase 3 trials, particularly for CAN-2409 in NSCLC. Discussions also highlight the upcoming CAN-3110 data release and its potential impact on the company's valuation. Some are speculating about potential partnerships and buyout opportunities.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals ($CRML) is trending as discussions revolve around its potential role in securing a domestic rare earth supply amid U.S.-China trade tensions. Community members are speculating on possible government funding and the impact of policy changes, highlighting the company's Greenland mine and the undervalued rare earth sector. Some traders are pointing to technical indicators, comparing it to other trending stocks, and expressing optimism for continued upward movement.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Best Momentum Stock to Buy for October 10th

SPRO made it to the Zacks Rank #1 (Strong Buy) momentum stock list on October 10, 2025.

Bayer Reports Positive Data on Cell Therapy for Parkinson's Disease 

BAYRY's subsidiary BlueRock reports 36-month data showing its Parkinson's therapy bemdaneprocel remains safe and effective in easing motor symptoms.

Down 17.7% in 4 Weeks, Here's Why Spero Therapeutics (SPRO) Looks Ripe for a Turnaround 

The heavy selling pressure might have exhausted for Spero Therapeutics (SPRO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Bayer Begins Phase I/II Study on Cell Therapy for Eye Disease

BAYRY begins human trials for OpCT-001, an experimental cell therapy for treating primary photoreceptor diseases.

AZN's Imfinzi Wins EU Nod for Muscle-Invasive Bladder Cancer

AstraZeneca secures EU approval for Imfinzi in muscle-invasive bladder cancer, expanding its cancer treatment portfolio.

Vertex Gets EU Nod for New Cystic Fibrosis Drug Alyftrek

VRTX secures EU approval for Alyftrek, a next-in-class triple combination regimen for treating people with CF aged six years and older.

RCKT's IND for RP-A701 in Dilated Cardiomyopathy Gets FDA Clearance

FDA clears Rocket Pharmaceuticals' IND for RP-A701, advancing its gene therapy for BAG3-linked dilated cardiomyopathy.

ABBV to Boost Immunology Pipeline With Capstan Buyout for $2.1B

AbbVie's $2.1 billion Capstan deal brings a novel in-vivo CAR-T therapy and tLNP platform to boost its immunology pipeline.

Vor Bio Stock Skyrockets 250% in the Past Week: Here's Why

The VOR stock soars in the past week after a licensing deal with RemeGen. The company also appoints a chief executive officer and chairman.

SPRO Stock Soars 245% on GSK-Partnered UTI Drug Meeting Study Goal

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, including multi-drug resistant bacterial infections, and rare diseases Its pipeline product candidates include Tebipenem HBr, SPR720, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.

Spero Therapeutics Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

SPRO
Spero Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest SPRO News

SPROSpero Therapeutics Inc